Accelerator Partnership

Right Brain Bio, Inc. (RBB) has been selected to participate in the Dassault Systèmes 3DEXPERIENCE Lab startup accelerator program. This selection provides RBB with access to the MEDIDATA clinical trial platform, which will enable the company to streamline trial execution and deliver high-quality results faster. The partnership is expected to benefit RBB as it prepares for Phase 2 development of its lead candidate, RB‑190, a patented small molecule designed to reduce dopamine production in the brain.